Session Information
-
WCLC 2017
18th World Conference on Lung Cancer
Conference Program for the 18th World Conference on Lung Cancer in Yokohama, Japan
Download PDF of the Conference Program: Click Here.
Onsite Conference Program Addendum (17/10/2017): Click Here.
Download PDF of the Abstract Book: Click Here.
Financial Disclosure Summary (PDF): Click Here.Presentation Date(s):- Oct 15 - 18, 2017
- Total Presentations: 2295
October 14 Sat
Oct 14 Sunday
October 15 Sun
Oct 15 Monday
October 16 Mon
Oct 16 Tuesday
October 17 Tue
Oct 17 Wednesday
October 18 Wed
Oct 18
-
+
P2.02 - Biology/Pathology
- 09:30 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Biology/Pathology
-
+
P2.02-058 - Endogenous Arginase 2 as a Biomarker for PEGylated Arginase 1 Treatment in Squamous Cell Lung Carcinoma Xenograft Models
09:30 - 09:30 | Presenter: Sze Kwan Lam | Author(s): Shi Xu, P.N. Cheng, J.C. Ho
- Abstract
Loading...
-
+
P2.15 - SCLC/Neuroendocrine Tumors
- 09:30 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: SCLC/Neuroendocrine Tumors
-
+
P2.15-006 - The Effects of Pegylated Arginase on Small Cell Lung Cancer in vitro and in vivo
09:30 - 09:30 | Presenter: Shi Xu | Author(s): Sze Kwan Lam, P.N. Cheng, J.C. Ho
- Abstract
Loading...
-
+
MA 07 - ALK, ROS and HER2
- 15:45 - 17:30
- 10/17/2017
- Location: Room 316
- Type: Mini Oral
- Track: Advanced NSCLC
- Moderators:Robert C. Doebele, J.C. Ho
-
+
MA 07.01 - Patients with ALK IHC-Positive/FISH-Negative NSCLC Benefit from ALK TKI Treatment: Response Data from the Global ALEX Trial
15:45 - 15:50 | Presenter: Tony SK Mok | Author(s): Solange Peters, D. Ross Camidge, Shirish M Gadgeel, S. Ignatius Ou, D. Kim, Rafal Dziadziuszko, F. De Marinis, R. Sangha, A. Zeaiter, J. Noe, E. Nueesch, T. Liu, Isabell Loftin, C. Williams, Alice Shaw
- Abstract
Loading... -
+
MA 07.02 - Response to Ensartinib in TKI Naïve ALK+ NSCLC Patients
15:50 - 15:55 | Presenter: Heather A Wakelee | Author(s): R.E. Sanborn, Jorge Nieva, S.N. Waqar, C. Brzezniak, J. Bauman, Joel W. Neal, G. Dukart, F. Tan, K. Harrow, C. Liang, L. Horn
- Abstract
Loading... -
+
MA 07.03 - Incidence, Predictors and Prognostic Significance of Thromboembolic Events in Patients with Advanced Alk-Rearranged NSCLCs
15:55 - 16:00 | Presenter: Jon Zugazagoitia | Author(s): M. Biosca, J.F. Grau, J. Olivera, L. Bei, M.E. Olmedo, A. Gómez Rueda, N. Muñoz, S. Ponce, M. Domine, V. Zenzola, Ernest Nadal, J.C. Ruffinelli, A.M. Luna, B. Hernández, M. Martínez, C. Font, M. García-Morillo, I. Gallego, D. Sánchez Cabrero, J. Miranda, E. Martínez De Castro, J.D. Cacho, V. Calvo, J. Martínez, E. Noguerón, R. Mondéjar, I. García Escobar, C. Salvador-Coloma, Ó. Juan, M. Sánchez Cánovas, J. Valdivia, M..P. Ochoa, R. López Castro, B. Obispo, C. Pangua, M. Sereno, L. Fernández Franco, X. Mielgo, J. Calzas, A. Blasco, F. Aparisi, L. Chara, D. Lora, A.J. Muñoz, Luis Paz-Ares, A. Manzano
- Abstract
Loading... -
+
- Abstract
Loading... -
+
MA 07.05 - Discussant - MA 07.01, MA 07.02, MA 07.03, MA 07.04
16:05 - 16:20 | Presenter: Neal Ready
- Abstract
No abstract available for this presentation
-
+
MA 07.06 - Detection of Mechanisms of Resistance to ALK Inhibitors in Routine Practice: A Retrospective Study
16:20 - 16:25 | Presenter: Philippe Jamme | Author(s): C. Descarpentries, M. Wislez, E. Dansin, V. Grégoire, S. Baldacci, F. Escande, N. Mathiot, M. Kyheng, Z. Kherrouche, M.C. Copin, Alexis B Cortot
- Abstract
Loading... -
+
MA 07.07 - Clinical Outcomes and ALK Resistance Mutations in ALK+ Non-Small Cell Lung Cancer According to EML4-ALK Variant
16:25 - 16:30 | Presenter: Jessica Jiyeong Lin | Author(s): Viola Zhu, S. Yoda, B.Y. Yeap, N.A. Jessop, A.B. Schrock, I. Dagogo-Jack, K. Gowen, P.J. Stephens, Jeffrey S. Ross, Siraj M Ali, V.A. Miller, Justin F Gainor, A.N. Hata, A.J. Iafrate, Sai-Hong Ignatius Ou, Alice Shaw
- Abstract
Loading... -
+
MA 07.08 - Clinical Implications of ALK Resistance Mutations: Institutional Experience and Launch of Remote Participation Study
16:30 - 16:35 | Presenter: Pablo Martinez | Author(s): N.R. Mahadevan, T. Nguyen, C.A. Lydon, L.M. Sholl, Pasi A Jänne, Geoffrey R. Oxnard
- Abstract
Loading... -
+
- Abstract
Loading... -
+
MA 07.10 - Discussant - MA 07.06, MA 07.07, MA 07.08, MA 07.09
16:40 - 16:55 | Presenter: Takashi Seto
- Abstract
No abstract available for this presentation
-
+
MA 07.11 - A Phase II Study of Trastuzumab Emtansine in HER2-positive Non-Small-Cell-Lung Cancer
16:55 - 17:00 | Presenter: Daijiro Harada | Author(s): T. Kozuki, N. Nogami, K. Hotta, K. Aoe, K. Ohashi, K. Ninomiya, T. Hirata, S. Hinotsu, Shinichi Toyooka, K. Kiura
- Abstract
Loading... -
+
MA 07.12 - Short-Term Culture of Patient Derived Tumor Organoids Identify Neratinib/Trastuzumab as an Effective Combination in HER2 Mutant Lung Cancer
17:00 - 17:05 | Presenter: Elena Ivanova | Author(s): M. Bahcall, A.R. Aref, T. Chen, L. Taus, F. Avogadri-Connors, R.E. Cutler Jr., A.S. Lalani, J. Choi, J.J. Haworth, E. Chambers, M. Kuraguchi, M. Xu, A.J. Redig, Kwok-Kin Wong, C.P. Paweletz, Pasi A Jänne
- Abstract
Loading... -
+
MA 07.13 - NGS Sequencing Based Liquid / Tissue Biopsy Identified Coexistence of HER2 Amplification and Mutation in Advanced NSCLC Patients
17:05 - 17:10 | Presenter: Rongrong Chen | Author(s): J. Zhao, G. Lin, Li Liu, Likun Chen, X. Hu, Xinghao Ai, Z. Fan, Chunwei Xu, W. Wang, Wu Zhuang, Meiyu Fang, Y. Zhu, Gang Chen, Y. Guan, L. Yang, X. Xia, X. Yi
- Abstract
Loading... -
+
MA 07.14 - Change in Practice Patterns from an Online NSCLC Treatment Decision Support Tool
17:10 - 17:15 | Presenter: David R. Gandara
- Abstract
No abstract available for this presentation
-
+
MA 07.15 - Discussant - MA 07.11, MA 07.12, MA 07.13
17:15 - 17:30 | Presenter: Chia-Chi Lin
- Abstract
No abstract available for this presentation
-
+
MA 07.15a - Q&A
17:30 - 17:35
- Abstract
No abstract available for this presentation